Future Pulse Cardiology

We would love to hear your thoughts on the episodes!

Although exercise usually provides a cardiovascular benefit, there is some data that points to an increase in event rates in extreme endurance athletes.  In this episode, Dr. Thomas Nero and Dr. Paul Thompson discuss the surprising findings regarding coronary calcium, cardiac troponins and atrial fibrillation in the endurance athlete and some thoughts about ideas to pursue in future research.

We would love to hear your thoughts on the episodes!

Dr Nero and Dr Thomposn discuss Statin Associated Muscle Symptoms (SAMS) and the results of the STOMP and SAMSON trials.  In addition, they discuss statins and athletic training, options for the statin intolerant patient and research regarding further investigation of the ranitadine receptor among other topics

We would love to hear your thoughts on the episodes!

Our inaugural podcast is a discussion between Dr. Paul Thompson, Chief of Cardiology, Emeritus, at Hartford Hospital and Professor of Medicine, Emeritus, at University of Connecticut and Dr. Thomas Nero, Director of Cardiovascular Research at CAFC about coronary artery disease, lipid sub-fractionation and the role of lipoprotein a, aka Lp(a).

We would love to hear your thoughts on the episodes!

I’m Dr Thomas Nero.  At Future Pulse our goal is to investigate the future of cardiovascular research and promote that discussion.

What is the next step and how will this trickle down to our clinical practice? What’s exciting and new in our field and why should we be interested.  

We will also look at the other side of the equation: how are we going to get these ideas off the ground?  How are we going to make the transition from theory to practice?  These discussions will involve benchtop researchers and clinical researchers as well as Venture capitalists and Industry Leaders.  We will pick the brains of our thought leaders, not just about where we are now but what the landscape will look like in the next 5-10 years.  Cardiology is an exciting and quickly evolving field and cardiovascular research is in the vanguard.  Come along with us and stay at the head of the pack